# Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device

> **NCT00867295** · PHASE3 · COMPLETED · sponsor: **Istanbul University** · enrollment: 150 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** cefazolin Sodium
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00867295
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867295, "Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00867295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*